Media stories about Colgate-Palmolive (NYSE:CL) have trended somewhat positive recently, InfoTrie reports. The research firm ranks the sentiment of news coverage by reviewing more than 6,000 blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Colgate-Palmolive earned a daily sentiment score of 0.57 on their scale. InfoTrie also gave media coverage about the company an news buzz score of 5 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company’s share price in the next few days.
These are some of the media stories that may have impacted Colgate-Palmolive’s analysis:
- Analysts watching Stock: Colgate-Palmolive Company (CL) (nasdaqclick.com)
- Traders pile into Colgate-Palmolive (cnbc.com)
- Jim Cramer: Do Some Buying but the Algos Will Not Let Up (finance.yahoo.com)
- Why Colgate-Palmolive Stock Lost 11% in October (fool.com)
- The Fear Of Missing Out Will Kill You: Colgate-Palmolive Company (CL), Newmont Mining Corporation (NEM) (gvtimes.com)
CL has been the subject of a number of research analyst reports. Zacks Investment Research lowered shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Friday, October 5th. Wells Fargo & Co reduced their price target on shares of Colgate-Palmolive from $64.00 to $62.00 and set a “market perform” rating for the company in a research note on Wednesday, October 17th. Morgan Stanley reduced their price target on shares of Colgate-Palmolive from $65.00 to $60.00 and set a “hold” rating for the company in a research note on Tuesday, October 30th. Citigroup reduced their price target on shares of Colgate-Palmolive from $70.00 to $68.00 and set a “neutral” rating for the company in a research note on Tuesday, July 31st. Finally, SunTrust Banks lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their price target for the stock from $80.00 to $65.00 in a research note on Friday, October 26th. Four equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company’s stock. Colgate-Palmolive presently has a consensus rating of “Hold” and an average target price of $68.06.
Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, October 26th. The company reported $0.72 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.72. The company had revenue of $3.85 billion for the quarter, compared to the consensus estimate of $3.89 billion. Colgate-Palmolive had a net margin of 13.55% and a return on equity of 12,004.60%. The firm’s revenue was down 3.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.73 earnings per share. As a group, analysts predict that Colgate-Palmolive will post 2.96 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 15th. Investors of record on Friday, October 19th will be issued a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.63%. The ex-dividend date is Thursday, October 18th. Colgate-Palmolive’s payout ratio is 58.54%.
In related news, VP Philip G. Shotts sold 462 shares of the firm’s stock in a transaction that occurred on Tuesday, September 11th. The shares were sold at an average price of $67.05, for a total value of $30,977.10. Following the transaction, the vice president now owns 41,250 shares of the company’s stock, valued at $2,765,812.50. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Philip G. Shotts sold 17,000 shares of the firm’s stock in a transaction that occurred on Tuesday, August 14th. The stock was sold at an average price of $65.44, for a total transaction of $1,112,480.00. Following the completion of the transaction, the vice president now directly owns 49,949 shares in the company, valued at approximately $3,268,662.56. The disclosure for this sale can be found here. In the last three months, insiders sold 149,811 shares of company stock worth $9,835,756. 1.02% of the stock is currently owned by insiders.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. It operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The company offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; personal care products comprising bar and liquid hand soaps, shower gels, shampoos, conditioners, and deodorants and antiperspirants; and home care products, such as laundry and dishwashing detergents, fabric conditioners, household cleaners, and other related products.
Recommended Story: Day Trading
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.